Literature DB >> 20479748

Manipulating proteostasis.

Richard N Sifers.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20479748     DOI: 10.1038/nchembio.374

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


× No keyword cloud information.
  9 in total

Review 1.  Setting the standards: quality control in the secretory pathway.

Authors:  L Ellgaard; M Molinari; A Helenius
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

Review 2.  Dissecting glycoprotein quality control in the secretory pathway.

Authors:  C M Cabral; Y Liu; R N Sifers
Journal:  Trends Biochem Sci       Date:  2001-10       Impact factor: 13.807

Review 3.  Therapeutic strategies to ameliorate lysosomal storage disorders--a focus on Gaucher disease.

Authors:  A R Sawkar; W D'Haeze; J W Kelly
Journal:  Cell Mol Life Sci       Date:  2006-05       Impact factor: 9.261

Review 4.  Biological and chemical approaches to diseases of proteostasis deficiency.

Authors:  Evan T Powers; Richard I Morimoto; Andrew Dillin; Jeffery W Kelly; William E Balch
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

5.  Endoplasmic reticulum Ca2+ increases enhance mutant glucocerebrosidase proteostasis.

Authors:  Derrick Sek Tong Ong; Ting-Wei Mu; Amy E Palmer; Jeffery W Kelly
Journal:  Nat Chem Biol       Date:  2010-05-09       Impact factor: 15.040

Review 6.  The proteostasis boundary in misfolding diseases of membrane traffic.

Authors:  Darren M Hutt; Evan T Powers; William E Balch
Journal:  FEBS Lett       Date:  2009-08-20       Impact factor: 4.124

7.  Chemical and biological approaches synergize to ameliorate protein-folding diseases.

Authors:  Ting-Wei Mu; Derrick Sek Tong Ong; Ya-Juan Wang; William E Balch; John R Yates; Laura Segatori; Jeffery W Kelly
Journal:  Cell       Date:  2008-09-05       Impact factor: 41.582

8.  Elucidation of the molecular logic by which misfolded alpha 1-antitrypsin is preferentially selected for degradation.

Authors:  Ying Wu; Matthew T Swulius; Kelley W Moremen; Richard N Sifers
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-18       Impact factor: 12.779

9.  Partial restoration of mutant enzyme homeostasis in three distinct lysosomal storage disease cell lines by altering calcium homeostasis.

Authors:  Ting-Wei Mu; Douglas M Fowler; Jeffery W Kelly
Journal:  PLoS Biol       Date:  2008-02       Impact factor: 8.029

  9 in total
  2 in total

1.  Compromised mutant EFEMP1 secretion associated with macular dystrophy remedied by proteostasis network alteration.

Authors:  John D Hulleman; Shalesh Kaushal; William E Balch; Jeffery W Kelly
Journal:  Mol Biol Cell       Date:  2011-10-26       Impact factor: 4.138

2.  Golgi-situated endoplasmic reticulum α-1, 2-mannosidase contributes to the retrieval of ERAD substrates through a direct interaction with γ-COP.

Authors:  Shujuan Pan; Xiaoyun Cheng; Richard N Sifers
Journal:  Mol Biol Cell       Date:  2013-02-20       Impact factor: 4.138

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.